NEW YORK (GenomeWeb News) – Bruker Daltonics and Kiestra Lab Automation said today that they have expanded a co-marketing and cross-selling partnership covering the use of their technologies in microbiology laboratories.
The companies have also signed a research and development agreement to integrate Bruker's MALDI Biotyper and Kiestra’s MalditofA, an automatic colony picker.
The MALDI Biotyper classifies microorganisms through proteomic fingerprinting via high-throughput MALDI-TOF mass spectrometry while the MalditofA is used to automatically transfer a colony to the target plate in order to prevent mismatches.
"Each of our technologies alone has been quite successful already, and in combination they could change the way microbiology is performed in many routine labs," said Wolfgang Pusch, vice president for clinical research solutions and in vitro diagnostics at Bruker Daltonics. "Both technologies integrated together will help microbiology laboratories to perform their important tasks faster and better, despite a predicted shortage in experienced laboratory staff."